Navigation Links
Drug-Eluting Peripheral Stent Continues to Show Positive Data at Two Years
Date:5/7/2010

SAN DIEGO, May 7 /PRNewswire/ -- Patients treated with the Zilver® PTX™ Drug-Eluting Peripheral Stent maintained clinical improvement at two years, according to interim results from the Zilver® PTX™ Global Registry presented today as a late-breaking clinical trial at the Society for Cardiovascular Angiography and Interventions (SCAI) 33rd Annual Scientific Sessions. The prospective, single-arm study is ongoing to evaluate the drug-eluting stent for the treatment of peripheral artery disease (PAD). Results of a separate pivotal randomized study in a similar cohort of patients are expected to be available later this year.

In the meantime, this analysis includes 12-month follow-up data from 721 patients and 24-month follow-up data from 447 patients who received the Zilver® PTX™ paclitaxel-coated stent in the superficial femoropopliteal artery (SFA), a major artery above the knee. The registry study was designed to evaluate stent integrity, event-free survival and freedom from target lesion revascularization.

PAD affects more than eight million people in the U.S. and, if not treated, can limit the ability to walk and exercise, as well as place patients at risk for limb loss. PAD patients also have a greater chance of heart attack, stroke and death.

Although use of DES is common in the coronary arteries, the peripheral arteries, including those in the legs, experience different types of stress caused by walking and other movement. In some instances, blockages in these arteries are very difficult to treat, and may ultimately lead to limb amputation. The study is the third to evaluate the effectiveness of a drug-eluting stent outside of the coronary arteries, but the first to suggest clinical efficacy. The Zilver® PTX™ is an investigational device.
'/>"/>

SOURCE SCAI
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Positive Long Term Data Presented at ACC 2010 Demonstrate Sustained Safety and Efficacy Advantages of the Cypher(R) Sirolimus Drug-Eluting Stent Over the Endeavor(R) Zotarolimus-Eluting Stent
2. Major Health Care Reforms in China Supported Growth of More Than 20% in the Drug-Eluting Stent Market in 2009, According to Millennium Research Group
3. Long Term Data Presented at EuroPCR 2009 from Randomized Study Attest to Durability of Results of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) Compared to Drug-Eluting Stents
4. Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent
5. Adoption of PCI in AMI Patients to Drive Drug-Eluting Stent Use
6. HORIZONS AMI Trial Demonstrates Superior Outcomes with TAXUS(R) Drug-Eluting Stents in Heart Attack Patients
7. Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent
8. Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents
9. Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents
10. Study Finds Taxus(R) Drug-Eluting Stent Beneficial in Treatment of Large Vessels
11. CardioMind Launches First-in-Human Trial of Small Vessel, Drug-Eluting Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... "Australia Capsule Endoscopy Systems Market Outlook to 2020″, provides ... market. The report provides value, in millions of US ... dollars) within market segments: Photo - ... , Capsule Endoscopy Data Recorders , Capsule Endoscopy ... shares and distribution shares data for each of these ...
(Date:7/25/2014)... , July 25, 2014  CVS Caremark Corporation ... conference call on Tuesday, August 5, 2014, at 8:30 ... second quarter 2014 financial results. An audio ... through the Investor Relations portion of the CVS Caremark ... visit http://info.cvscaremark.com/investors . This webcast will be archived ...
(Date:7/25/2014)... , July 25, 2014  Solanbridge Group Inc ... acquired the majority interest in Buzznbrewz.com and the Letter ... replaced with a fully executed Purchase Agreement. ... stated "We are proud to have Mr. David ... decades of experience in the private sector and developed ...
Breaking Medicine Technology:Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 2Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 3Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 4Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 5Solanbridge Group Inc Announces Acquisition of Buzznbrewz.com 2
... Re-Activates the, Tumor Suppressor P53 Inhibited Tumor Growth Synergistically in Preclinical ... ... April 14 ,Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) announced today ... the 2008 Annual Meeting of the American Association for Cancer Research,(AACR) ...
... feedback validates HUYA,s Integrated Co-Development Model for ... ... HUYA Bioscience International,(HUYA), the leader in U.S./China pharmaceutical co-development, ... Drug),consultation with the U.S. FDA for a development-stage compound ...
Cached Medicine Technology:Preclinical Study Presented at AACR Annual Meeting Shows Broad Anti-Cancer Potential of Peregrine's anti-PS Vascular Targeting Antibodies 2Preclinical Study Presented at AACR Annual Meeting Shows Broad Anti-Cancer Potential of Peregrine's anti-PS Vascular Targeting Antibodies 3Preclinical Study Presented at AACR Annual Meeting Shows Broad Anti-Cancer Potential of Peregrine's anti-PS Vascular Targeting Antibodies 4HUYA Bioscience Int'l Announces First Pre-IND Outcome for a Development Stage Compound Sourced From China - HBI-8000, Promising New Cancer Compound 2HUYA Bioscience Int'l Announces First Pre-IND Outcome for a Development Stage Compound Sourced From China - HBI-8000, Promising New Cancer Compound 3HUYA Bioscience Int'l Announces First Pre-IND Outcome for a Development Stage Compound Sourced From China - HBI-8000, Promising New Cancer Compound 4
(Date:7/28/2014)... at North Carolina State University is proposing a new ... ability with age, but don,t necessarily show declines in ... be how motivated older adults are to maintain focus ... wanted to explain the difference we see in cognitive ... professor of psychology at NC State and author of ...
(Date:7/28/2014)... July 28, 2014 Top Northridge dentist ... for new patients. Finding a new dentist can be an ... issues that have gone untreated and worry about how they ... specializes in patients with special concerns and dental needs and ... and right at home. This special coupon can help patients ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 Freeonlinelifeinsuranceleads.com has ... advantages of comparing online life insurance quotes. , Comparing ... 40% of their life insurance costs. Finding affordable coverage ... websites gather quotes from reliable agencies and displays them ... life insurance quotes, clients can find cheaper coverage, but ...
(Date:7/28/2014)... a healthy lifestyle may help childhood cancer survivors reduce ... indicates. Researchers suggested that children with cancer and ... about how their diet and certain behaviors could ... are important because they indicate that adults who were ... influence their own health outcomes," said one of the ...
(Date:7/28/2014)... 2014 Mahendra Trivedi, accompanied by Trivedi ... Online Workshop ‘Consciousness is Power’ on July 26, 2014 ... workshop, participants from all over the world received profound ... deeper connection to their inner guidance system. , On ... various advantages of raising consciousness and thus, enjoying the ...
Breaking Medicine News(10 mins):Health News:Motivation explains disconnect between testing and real-life functioning for seniors 2Health News:Northridge Dentist, Dr. Farshid Ariz, is Now Offering a $100 Coupon for New Patients 2Health News:Comparing Life Insurance Quotes Online Offers 3 Important Advantages! 2Health News:Healthy Habits May Help Childhood Cancer Survivors Avoid Chronic Ills 2Health News:Trivedi Online Workshop ‘Consciousness is Power’ was Huge Success 2Health News:Trivedi Online Workshop ‘Consciousness is Power’ was Huge Success 3
... THURSDAY, March 5 (HealthDay News) -- If you,re over 50, ... third glass of wine as well as you used to, ... adults who are social drinkers can become impaired by alcohol ... University of Kentucky researchers report. , Most studies on ...
... 2009) -- Two highly lethal viruses that have emerged in ... to prevent and treat malaria, according to a new basic ... the Journal of Virology . Due to the study,s ... print issue, and will be highlighted as an,editor,s "spotlight" in ...
... information about potential risk from exposure to medications, chemicals ... about potential risks of taking cold medication or using ... and over the phone. A new Web ... source for finding the latest information about the potential ...
... broccoli, cabbage block protein in disease spread, study says ... based on compounds extracted from cruciferous vegetables such as ... treatment against melanoma, Penn State College of Medicine researchers ... compounds (called isothiocyanates) and selenium slowed production and blocked ...
... Supreme Court ruling against preemption is disastrous for patient ... and clearly elevates trial lawyers and local juries as ... court has decided that federal law does not preempt ... a flood of frivolous liability lawsuits will cause patients ...
... failure, stroke and heart disease are potential complications of ... million Americans. Now research from Tel Aviv University has ... be a risk factor accelerating cognitive decline and dementia. ... from TAU,s Sackler School of Medicine, found that people ...
Cached Medicine News:Health News:Older Adults Get Drunk Faster Than Younger Drinkers 2Health News:Older Adults Get Drunk Faster Than Younger Drinkers 3Health News:Drug blocks two of world's deadliest emerging viruses 2Health News:Drug blocks two of world's deadliest emerging viruses 3Health News:New Online Service Helps Expectant Moms 2Health News:Drugs From Vegetables May Target Melanoma Tumors 2Health News:High Court Ruling Against Preemption Hurts Patients, Helps Trial Lawyers 2Health News:New Tel Aviv University research links diabetes to cognitive deterioration 2
... The ACMI USA Series DUR-8 Durable ... to the entire intrarenal collecting system with ... and superior secondary deflection allow complete intrarenal ... deflection facilitates access to the proximal ureter ...
... combines efficient stone fragmentation, low purchase price, ... clear LED display, automatic probe sensing circuitry, ... probe size. In addition, the AEH-4E has ... can also regulate and control relative power ...
P-Series Cystourethroscope Short Bridge, examining...
Short double-horn bridge for insertion of instruments...
Medicine Products: